Page 405 - 16Neonatal Jaundice_compressed
P. 405

Appendix H: Evidence tables


 Bibliographic   Study Type &   Number of   Intervention & Comparison   Dichotomous outcomes   Continuous Outcomes
 Information   Evidence Level   Patients/Characteristics   (E:C)   (Mean:SD: N)
 Congenital nonbacterial   and was increased if TSB   RR = 1.05 (95% CI: 0.90,
 infection,   > 222 micromol/litre in BW 501 – 750 g  1.22)
 Judgement at parents may be   or
 able to return for final   TSB > 256 in BW 751 – 1000 g   Neurodevelopmental
 assessment at 18 – 22 months      impairment
    Exchange transfusion was indicated   Group 1: 235/902
 Demographics:   TSB exceeded threshold after 8 hours of  Group 2: 275/902
 Gender (M/F) : 1013/961   intensive phototherapy    RR = 0.86 (95% CI: 0.74,
 Mean GA: 26.0 ± 2.0 weeks   0.99)

 Mean BW: 777 ± 134 g
 Mean age at entry to study: Not
 reported
 Mean TSB: Not reported for all
 babies
 Author:   Methodology:   N:   Group 1:      Max TSB:
 Valdes O   RCT   75   Phenobarbital      Group 1: 96 ± 57 micromol/litre

 Year:   Blinding:   Inclusion:   Group 2:   Group 2: 58 ± 52 micromol/litre
 1971   Not reported   Birthweight < 2500 g   Phototherapy   Group 3: 63 ± 58 micromol/litre

 Country:   Randomisation:   Exclusion:   Group 3:   Group 4: 140 ± 53 micromol/litre
 USA   Not reported   Positive Coombs test,   Phenobarbital + Phototherapy
       ABO incompatibility,
 ID:     Evidence level:   Sepsis   Group 4:
 146
 1 -      No treatment
     Demographics:
 Gender (M/F): Not reported
 Mean GA: Not reported
 Mean BW: 1766 g
 Age at entry to study:
 Not reported
 Mean TSB: Not reported
 Author: Costello S   Methodology:   N: 44   Group 1:   ET:   Mean duration of phototherapy
    RCT      Conventional Phototherapy   Group 1: 0/24   Group 1: 44.0 ± 42.8 hours
 Year:      Inclusion:      Group 2: 0/20
 1994   Blinding:   Gestational age between 27 and  Group 2:      Group 2: 42.0 ± 39.1 hours
    Not reported   36 weeks   Fiberoptic phototherapy   Treatment failure:
 Country:      TSB > 125 micromol/litre)      Group 1: 3/24
 Australia   Randomisation:   (increased with age (hours) and  Conventional phototherapy consisted of  Group 2: 1/20   Max TSB:
    Lottery method   birthweight   a standard system of four white and 4      Group 1: 210 ± 58 micromol/litre
 156
 ID:           blue fluorescent lamps 50cm above the
 Evidence level:   Exclusion:   baby with an intensity of      Group 2: 198 ± 53 micromol/litre
 2
 1 +   Not reported   8 microW/cm /nm

 Demographics:   Fiberoptic phototherapy (BiliBlanket)
 Gender (M/F): Not reported
 with a constant setting of

                                                                 275
   400   401   402   403   404   405   406   407   408   409   410